Pharma & Healthcare
Global Daptomycin API Market Research Report 2025
- Nov 04, 25
- ID: 404994
- Pages: 81
- Figures: 84
- Views: 15
Report Scope
This report aims to provide a comprehensive presentation of the global market for Daptomycin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daptomycin API.
The Daptomycin API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daptomycin API market comprehensively. Regional market sizes, concerning products by Type, by Application, by Marketing Channel and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daptomycin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Marketing Channel and by regions.
By Company
Xellia Pharmaceuticals
Rochem International Inc
Tecoland Corporation
Livzon Group Fuzhou Fuxing Pharmaceutical Co
Chongqing DaXin Pharmaceutical Co
Suzhou Pharmaceutical Technology Co
Huazhong Pharmaceutical Co
Athos
Segment by Type
99%
98%
Others
Segment by Marketing Channel
Direct Sales
Channel Sales
Segment by Application
350mg/vial
500mg/vial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daptomycin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daptomycin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Daptomycin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daptomycin API.
The Daptomycin API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daptomycin API market comprehensively. Regional market sizes, concerning products by Type, by Application, by Marketing Channel and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daptomycin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Marketing Channel and by regions.
By Company
Xellia Pharmaceuticals
Rochem International Inc
Tecoland Corporation
Livzon Group Fuzhou Fuxing Pharmaceutical Co
Chongqing DaXin Pharmaceutical Co
Suzhou Pharmaceutical Technology Co
Huazhong Pharmaceutical Co
Athos
Segment by Type
99%
98%
Others
Segment by Marketing Channel
Direct Sales
Channel Sales
Segment by Application
350mg/vial
500mg/vial
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Daptomycin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Daptomycin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Daptomycin API Market Overview
1.1 Product Definition
1.2 Daptomycin API by Type
1.2.1 Global Daptomycin API Market Value Comparison by Type (2024 VS 2031)
1.2.2 99%
1.2.3 98%
1.2.4 Others
1.3 Daptomycin API by Marketing Channel
1.3.1 Global Daptomycin API Market Value Comparison by Marketing Channel: 2024 VS 2031
1.3.2 Direct Sales
1.3.3 Channel Sales
1.4 Daptomycin API by Application
1.4.1 Global Daptomycin API Market Value by Application (2024 VS 2031)
1.4.2 350mg/vial
1.4.3 500mg/vial
1.4.4 Others
1.5 Global Daptomycin API Market Size Estimates and Forecasts
1.5.1 Global Daptomycin API Revenue 2020-2031
1.5.2 Global Daptomycin API Sales 2020-2031
1.5.3 Global Daptomycin API Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Daptomycin API Market Competition by Manufacturers
2.1 Global Daptomycin API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daptomycin API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daptomycin API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daptomycin API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daptomycin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daptomycin API, Product Type & Application
2.7 Global Key Manufacturers of Daptomycin API, Date of Enter into This Industry
2.8 Global Daptomycin API Market Competitive Situation and Trends
2.8.1 Global Daptomycin API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daptomycin API Players Market Share by Revenue
2.8.3 Global Daptomycin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daptomycin API Market Scenario by Region
3.1 Global Daptomycin API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daptomycin API Sales by Region: 2020-2031
3.2.1 Global Daptomycin API Sales by Region: 2020-2025
3.2.2 Global Daptomycin API Sales by Region: 2026-2031
3.3 Global Daptomycin API Revenue by Region: 2020-2031
3.3.1 Global Daptomycin API Revenue by Region: 2020-2025
3.3.2 Global Daptomycin API Revenue by Region: 2026-2031
3.4 North America Daptomycin API Market Facts & Figures by Country
3.4.1 North America Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daptomycin API Sales by Country (2020-2031)
3.4.3 North America Daptomycin API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daptomycin API Market Facts & Figures by Country
3.5.1 Europe Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daptomycin API Sales by Country (2020-2031)
3.5.3 Europe Daptomycin API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daptomycin API Market Facts & Figures by Region
3.6.1 Asia Pacific Daptomycin API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daptomycin API Sales by Region (2020-2031)
3.6.3 Asia Pacific Daptomycin API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Daptomycin API Market Facts & Figures by Country
3.7.1 Latin America Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daptomycin API Sales by Country (2020-2031)
3.7.3 Latin America Daptomycin API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Daptomycin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daptomycin API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daptomycin API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daptomycin API Sales by Type (2020-2031)
4.1.1 Global Daptomycin API Sales by Type (2020-2025)
4.1.2 Global Daptomycin API Sales by Type (2026-2031)
4.1.3 Global Daptomycin API Sales Market Share by Type (2020-2031)
4.2 Global Daptomycin API Revenue by Type (2020-2031)
4.2.1 Global Daptomycin API Revenue by Type (2020-2025)
4.2.2 Global Daptomycin API Revenue by Type (2026-2031)
4.2.3 Global Daptomycin API Revenue Market Share by Type (2020-2031)
4.3 Global Daptomycin API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daptomycin API Sales by Application (2020-2031)
5.1.1 Global Daptomycin API Sales by Application (2020-2025)
5.1.2 Global Daptomycin API Sales by Application (2026-2031)
5.1.3 Global Daptomycin API Sales Market Share by Application (2020-2031)
5.2 Global Daptomycin API Revenue by Application (2020-2031)
5.2.1 Global Daptomycin API Revenue by Application (2020-2025)
5.2.2 Global Daptomycin API Revenue by Application (2026-2031)
5.2.3 Global Daptomycin API Revenue Market Share by Application (2020-2031)
5.3 Global Daptomycin API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Xellia Pharmaceuticals
6.1.1 Xellia Pharmaceuticals Company Information
6.1.2 Xellia Pharmaceuticals Description and Business Overview
6.1.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Xellia Pharmaceuticals Daptomycin API Product Portfolio
6.1.5 Xellia Pharmaceuticals Recent Developments/Updates
6.2 Rochem International Inc
6.2.1 Rochem International Inc Company Information
6.2.2 Rochem International Inc Description and Business Overview
6.2.3 Rochem International Inc Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Rochem International Inc Daptomycin API Product Portfolio
6.2.5 Rochem International Inc Recent Developments/Updates
6.3 Tecoland Corporation
6.3.1 Tecoland Corporation Company Information
6.3.2 Tecoland Corporation Description and Business Overview
6.3.3 Tecoland Corporation Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tecoland Corporation Daptomycin API Product Portfolio
6.3.5 Tecoland Corporation Recent Developments/Updates
6.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co
6.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
6.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
6.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio
6.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
6.5 Chongqing DaXin Pharmaceutical Co
6.5.1 Chongqing DaXin Pharmaceutical Co Company Information
6.5.2 Chongqing DaXin Pharmaceutical Co Description and Business Overview
6.5.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio
6.5.5 Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
6.6 Suzhou Pharmaceutical Technology Co
6.6.1 Suzhou Pharmaceutical Technology Co Company Information
6.6.2 Suzhou Pharmaceutical Technology Co Description and Business Overview
6.6.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio
6.6.5 Suzhou Pharmaceutical Technology Co Recent Developments/Updates
6.7 Huazhong Pharmaceutical Co
6.7.1 Huazhong Pharmaceutical Co Company Information
6.7.2 Huazhong Pharmaceutical Co Description and Business Overview
6.7.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huazhong Pharmaceutical Co Daptomycin API Product Portfolio
6.7.5 Huazhong Pharmaceutical Co Recent Developments/Updates
6.8 Athos
6.8.1 Athos Company Information
6.8.2 Athos Description and Business Overview
6.8.3 Athos Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Athos Daptomycin API Product Portfolio
6.8.5 Athos Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daptomycin API Industry Chain Analysis
7.2 Daptomycin API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daptomycin API Production Mode & Process Analysis
7.4 Daptomycin API Sales and Marketing
7.4.1 Daptomycin API Sales Channels
7.4.2 Daptomycin API Distributors
7.5 Daptomycin API Customer Analysis
8 Daptomycin API Market Dynamics
8.1 Daptomycin API Industry Trends
8.2 Daptomycin API Market Drivers
8.3 Daptomycin API Market Challenges
8.4 Daptomycin API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Daptomycin API by Type
1.2.1 Global Daptomycin API Market Value Comparison by Type (2024 VS 2031)
1.2.2 99%
1.2.3 98%
1.2.4 Others
1.3 Daptomycin API by Marketing Channel
1.3.1 Global Daptomycin API Market Value Comparison by Marketing Channel: 2024 VS 2031
1.3.2 Direct Sales
1.3.3 Channel Sales
1.4 Daptomycin API by Application
1.4.1 Global Daptomycin API Market Value by Application (2024 VS 2031)
1.4.2 350mg/vial
1.4.3 500mg/vial
1.4.4 Others
1.5 Global Daptomycin API Market Size Estimates and Forecasts
1.5.1 Global Daptomycin API Revenue 2020-2031
1.5.2 Global Daptomycin API Sales 2020-2031
1.5.3 Global Daptomycin API Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Daptomycin API Market Competition by Manufacturers
2.1 Global Daptomycin API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daptomycin API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daptomycin API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daptomycin API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daptomycin API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daptomycin API, Product Type & Application
2.7 Global Key Manufacturers of Daptomycin API, Date of Enter into This Industry
2.8 Global Daptomycin API Market Competitive Situation and Trends
2.8.1 Global Daptomycin API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daptomycin API Players Market Share by Revenue
2.8.3 Global Daptomycin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daptomycin API Market Scenario by Region
3.1 Global Daptomycin API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daptomycin API Sales by Region: 2020-2031
3.2.1 Global Daptomycin API Sales by Region: 2020-2025
3.2.2 Global Daptomycin API Sales by Region: 2026-2031
3.3 Global Daptomycin API Revenue by Region: 2020-2031
3.3.1 Global Daptomycin API Revenue by Region: 2020-2025
3.3.2 Global Daptomycin API Revenue by Region: 2026-2031
3.4 North America Daptomycin API Market Facts & Figures by Country
3.4.1 North America Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daptomycin API Sales by Country (2020-2031)
3.4.3 North America Daptomycin API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daptomycin API Market Facts & Figures by Country
3.5.1 Europe Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daptomycin API Sales by Country (2020-2031)
3.5.3 Europe Daptomycin API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daptomycin API Market Facts & Figures by Region
3.6.1 Asia Pacific Daptomycin API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daptomycin API Sales by Region (2020-2031)
3.6.3 Asia Pacific Daptomycin API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Daptomycin API Market Facts & Figures by Country
3.7.1 Latin America Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daptomycin API Sales by Country (2020-2031)
3.7.3 Latin America Daptomycin API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Daptomycin API Market Facts & Figures by Country
3.8.1 Middle East and Africa Daptomycin API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daptomycin API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daptomycin API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daptomycin API Sales by Type (2020-2031)
4.1.1 Global Daptomycin API Sales by Type (2020-2025)
4.1.2 Global Daptomycin API Sales by Type (2026-2031)
4.1.3 Global Daptomycin API Sales Market Share by Type (2020-2031)
4.2 Global Daptomycin API Revenue by Type (2020-2031)
4.2.1 Global Daptomycin API Revenue by Type (2020-2025)
4.2.2 Global Daptomycin API Revenue by Type (2026-2031)
4.2.3 Global Daptomycin API Revenue Market Share by Type (2020-2031)
4.3 Global Daptomycin API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daptomycin API Sales by Application (2020-2031)
5.1.1 Global Daptomycin API Sales by Application (2020-2025)
5.1.2 Global Daptomycin API Sales by Application (2026-2031)
5.1.3 Global Daptomycin API Sales Market Share by Application (2020-2031)
5.2 Global Daptomycin API Revenue by Application (2020-2031)
5.2.1 Global Daptomycin API Revenue by Application (2020-2025)
5.2.2 Global Daptomycin API Revenue by Application (2026-2031)
5.2.3 Global Daptomycin API Revenue Market Share by Application (2020-2031)
5.3 Global Daptomycin API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Xellia Pharmaceuticals
6.1.1 Xellia Pharmaceuticals Company Information
6.1.2 Xellia Pharmaceuticals Description and Business Overview
6.1.3 Xellia Pharmaceuticals Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Xellia Pharmaceuticals Daptomycin API Product Portfolio
6.1.5 Xellia Pharmaceuticals Recent Developments/Updates
6.2 Rochem International Inc
6.2.1 Rochem International Inc Company Information
6.2.2 Rochem International Inc Description and Business Overview
6.2.3 Rochem International Inc Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Rochem International Inc Daptomycin API Product Portfolio
6.2.5 Rochem International Inc Recent Developments/Updates
6.3 Tecoland Corporation
6.3.1 Tecoland Corporation Company Information
6.3.2 Tecoland Corporation Description and Business Overview
6.3.3 Tecoland Corporation Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Tecoland Corporation Daptomycin API Product Portfolio
6.3.5 Tecoland Corporation Recent Developments/Updates
6.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co
6.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
6.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
6.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product Portfolio
6.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
6.5 Chongqing DaXin Pharmaceutical Co
6.5.1 Chongqing DaXin Pharmaceutical Co Company Information
6.5.2 Chongqing DaXin Pharmaceutical Co Description and Business Overview
6.5.3 Chongqing DaXin Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chongqing DaXin Pharmaceutical Co Daptomycin API Product Portfolio
6.5.5 Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
6.6 Suzhou Pharmaceutical Technology Co
6.6.1 Suzhou Pharmaceutical Technology Co Company Information
6.6.2 Suzhou Pharmaceutical Technology Co Description and Business Overview
6.6.3 Suzhou Pharmaceutical Technology Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Suzhou Pharmaceutical Technology Co Daptomycin API Product Portfolio
6.6.5 Suzhou Pharmaceutical Technology Co Recent Developments/Updates
6.7 Huazhong Pharmaceutical Co
6.7.1 Huazhong Pharmaceutical Co Company Information
6.7.2 Huazhong Pharmaceutical Co Description and Business Overview
6.7.3 Huazhong Pharmaceutical Co Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Huazhong Pharmaceutical Co Daptomycin API Product Portfolio
6.7.5 Huazhong Pharmaceutical Co Recent Developments/Updates
6.8 Athos
6.8.1 Athos Company Information
6.8.2 Athos Description and Business Overview
6.8.3 Athos Daptomycin API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Athos Daptomycin API Product Portfolio
6.8.5 Athos Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daptomycin API Industry Chain Analysis
7.2 Daptomycin API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daptomycin API Production Mode & Process Analysis
7.4 Daptomycin API Sales and Marketing
7.4.1 Daptomycin API Sales Channels
7.4.2 Daptomycin API Distributors
7.5 Daptomycin API Customer Analysis
8 Daptomycin API Market Dynamics
8.1 Daptomycin API Industry Trends
8.2 Daptomycin API Market Drivers
8.3 Daptomycin API Market Challenges
8.4 Daptomycin API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Daptomycin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Daptomycin API Market Value by Marketing Channel, (US$ Million) & (2024 VS 2031)
Table 3. Global Daptomycin API Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Daptomycin API Market Competitive Situation by Manufacturers in 2024
Table 5. Global Daptomycin API Sales (Tons) of Key Manufacturers (2020-2025)
Table 6. Global Daptomycin API Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Daptomycin API Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Daptomycin API Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Daptomycin API Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Daptomycin API, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Daptomycin API, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Daptomycin API, Product Type & Application
Table 13. Global Key Manufacturers of Daptomycin API, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Daptomycin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daptomycin API as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Daptomycin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Daptomycin API Sales by Region (2020-2025) & (Tons)
Table 19. Global Daptomycin API Sales Market Share by Region (2020-2025)
Table 20. Global Daptomycin API Sales by Region (2026-2031) & (Tons)
Table 21. Global Daptomycin API Sales Market Share by Region (2026-2031)
Table 22. Global Daptomycin API Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Daptomycin API Revenue Market Share by Region (2020-2025)
Table 24. Global Daptomycin API Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Daptomycin API Revenue Market Share by Region (2026-2031)
Table 26. North America Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 28. North America Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 29. North America Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 33. Europe Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 34. Europe Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Daptomycin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Daptomycin API Sales by Region (2020-2025) & (Tons)
Table 38. Asia Pacific Daptomycin API Sales by Region (2026-2031) & (Tons)
Table 39. Asia Pacific Daptomycin API Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Daptomycin API Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 43. Latin America Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 44. Latin America Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 48. Middle East and Africa Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 49. Middle East and Africa Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Daptomycin API Sales (Tons) by Type (2020-2025)
Table 52. Global Daptomycin API Sales (Tons) by Type (2026-2031)
Table 53. Global Daptomycin API Sales Market Share by Type (2020-2025)
Table 54. Global Daptomycin API Sales Market Share by Type (2026-2031)
Table 55. Global Daptomycin API Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Daptomycin API Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Daptomycin API Revenue Market Share by Type (2020-2025)
Table 58. Global Daptomycin API Revenue Market Share by Type (2026-2031)
Table 59. Global Daptomycin API Price (US$/Ton) by Type (2020-2025)
Table 60. Global Daptomycin API Price (US$/Ton) by Type (2026-2031)
Table 61. Global Daptomycin API Sales (Tons) by Application (2020-2025)
Table 62. Global Daptomycin API Sales (Tons) by Application (2026-2031)
Table 63. Global Daptomycin API Sales Market Share by Application (2020-2025)
Table 64. Global Daptomycin API Sales Market Share by Application (2026-2031)
Table 65. Global Daptomycin API Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Daptomycin API Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Daptomycin API Revenue Market Share by Application (2020-2025)
Table 68. Global Daptomycin API Revenue Market Share by Application (2026-2031)
Table 69. Global Daptomycin API Price (US$/Ton) by Application (2020-2025)
Table 70. Global Daptomycin API Price (US$/Ton) by Application (2026-2031)
Table 71. Xellia Pharmaceuticals Company Information
Table 72. Xellia Pharmaceuticals Description and Business Overview
Table 73. Xellia Pharmaceuticals Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 74. Xellia Pharmaceuticals Daptomycin API Product
Table 75. Xellia Pharmaceuticals Recent Developments/Updates
Table 76. Rochem International Inc Company Information
Table 77. Rochem International Inc Description and Business Overview
Table 78. Rochem International Inc Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 79. Rochem International Inc Daptomycin API Product
Table 80. Rochem International Inc Recent Developments/Updates
Table 81. Tecoland Corporation Company Information
Table 82. Tecoland Corporation Description and Business Overview
Table 83. Tecoland Corporation Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Tecoland Corporation Daptomycin API Product
Table 85. Tecoland Corporation Recent Developments/Updates
Table 86. Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
Table 87. Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
Table 88. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 89. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product
Table 90. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
Table 91. Chongqing DaXin Pharmaceutical Co Company Information
Table 92. Chongqing DaXin Pharmaceutical Co Description and Business Overview
Table 93. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 94. Chongqing DaXin Pharmaceutical Co Daptomycin API Product
Table 95. Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
Table 96. Suzhou Pharmaceutical Technology Co Company Information
Table 97. Suzhou Pharmaceutical Technology Co Description and Business Overview
Table 98. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 99. Suzhou Pharmaceutical Technology Co Daptomycin API Product
Table 100. Suzhou Pharmaceutical Technology Co Recent Developments/Updates
Table 101. Huazhong Pharmaceutical Co Company Information
Table 102. Huazhong Pharmaceutical Co Description and Business Overview
Table 103. Huazhong Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 104. Huazhong Pharmaceutical Co Daptomycin API Product
Table 105. Huazhong Pharmaceutical Co Recent Developments/Updates
Table 106. Athos Company Information
Table 107. Athos Description and Business Overview
Table 108. Athos Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 109. Athos Daptomycin API Product
Table 110. Athos Recent Developments/Updates
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Daptomycin API Distributors List
Table 114. Daptomycin API Customers List
Table 115. Daptomycin API Market Trends
Table 116. Daptomycin API Market Drivers
Table 117. Daptomycin API Market Challenges
Table 118. Daptomycin API Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Product Picture of Daptomycin API
Figure 2. Global Daptomycin API Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Daptomycin API Market Share by Type: 2024 & 2031
Figure 4. 99% Product Picture
Figure 5. 98% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Daptomycin API Market Value by Marketing Channel, (US$ Million) & (2020-2031)
Figure 8. Global Daptomycin API Market Share by Marketing Channel: 2024 VS 2031
Figure 9. Direct Sales Product Picture
Figure 10. Channel Sales Product Picture
Figure 11. Global Daptomycin API Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Daptomycin API Market Share by Application: 2024 & 2031
Figure 13. 350mg/vial
Figure 14. 500mg/vial
Figure 15. Others
Figure 16. Global Daptomycin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Daptomycin API Market Size (2020-2031) & (US$ Million)
Figure 18. Global Daptomycin API Sales (2020-2031) & (Tons)
Figure 19. Global Daptomycin API Average Price (US$/Ton) & (2020-2031)
Figure 20. Daptomycin API Report Years Considered
Figure 21. Daptomycin API Sales Share by Manufacturers in 2024
Figure 22. Global Daptomycin API Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Daptomycin API Players: Market Share by Revenue in Daptomycin API in 2024
Figure 24. Daptomycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Daptomycin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Daptomycin API Sales Market Share by Country (2020-2031)
Figure 27. North America Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 28. United States Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Daptomycin API Sales Market Share by Country (2020-2031)
Figure 31. Europe Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 32. Germany Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Daptomycin API Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Daptomycin API Revenue Market Share by Region (2020-2031)
Figure 39. China Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Daptomycin API Sales Market Share by Country (2020-2031)
Figure 49. Latin America Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Daptomycin API Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Daptomycin API by Type (2020-2031)
Figure 59. Global Revenue Market Share of Daptomycin API by Type (2020-2031)
Figure 60. Global Daptomycin API Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Sales Market Share of Daptomycin API by Application (2020-2031)
Figure 62. Global Revenue Market Share of Daptomycin API by Application (2020-2031)
Figure 63. Global Daptomycin API Price (US$/Ton) by Application (2020-2031)
Figure 64. Daptomycin API Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Daptomycin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Daptomycin API Market Value by Marketing Channel, (US$ Million) & (2024 VS 2031)
Table 3. Global Daptomycin API Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Daptomycin API Market Competitive Situation by Manufacturers in 2024
Table 5. Global Daptomycin API Sales (Tons) of Key Manufacturers (2020-2025)
Table 6. Global Daptomycin API Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Daptomycin API Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Daptomycin API Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Daptomycin API Average Price (US$/Ton) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Daptomycin API, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Daptomycin API, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Daptomycin API, Product Type & Application
Table 13. Global Key Manufacturers of Daptomycin API, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Daptomycin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daptomycin API as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Daptomycin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Daptomycin API Sales by Region (2020-2025) & (Tons)
Table 19. Global Daptomycin API Sales Market Share by Region (2020-2025)
Table 20. Global Daptomycin API Sales by Region (2026-2031) & (Tons)
Table 21. Global Daptomycin API Sales Market Share by Region (2026-2031)
Table 22. Global Daptomycin API Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Daptomycin API Revenue Market Share by Region (2020-2025)
Table 24. Global Daptomycin API Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Daptomycin API Revenue Market Share by Region (2026-2031)
Table 26. North America Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 28. North America Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 29. North America Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 33. Europe Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 34. Europe Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Daptomycin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Daptomycin API Sales by Region (2020-2025) & (Tons)
Table 38. Asia Pacific Daptomycin API Sales by Region (2026-2031) & (Tons)
Table 39. Asia Pacific Daptomycin API Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Daptomycin API Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 43. Latin America Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 44. Latin America Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Daptomycin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Daptomycin API Sales by Country (2020-2025) & (Tons)
Table 48. Middle East and Africa Daptomycin API Sales by Country (2026-2031) & (Tons)
Table 49. Middle East and Africa Daptomycin API Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Daptomycin API Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Daptomycin API Sales (Tons) by Type (2020-2025)
Table 52. Global Daptomycin API Sales (Tons) by Type (2026-2031)
Table 53. Global Daptomycin API Sales Market Share by Type (2020-2025)
Table 54. Global Daptomycin API Sales Market Share by Type (2026-2031)
Table 55. Global Daptomycin API Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Daptomycin API Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Daptomycin API Revenue Market Share by Type (2020-2025)
Table 58. Global Daptomycin API Revenue Market Share by Type (2026-2031)
Table 59. Global Daptomycin API Price (US$/Ton) by Type (2020-2025)
Table 60. Global Daptomycin API Price (US$/Ton) by Type (2026-2031)
Table 61. Global Daptomycin API Sales (Tons) by Application (2020-2025)
Table 62. Global Daptomycin API Sales (Tons) by Application (2026-2031)
Table 63. Global Daptomycin API Sales Market Share by Application (2020-2025)
Table 64. Global Daptomycin API Sales Market Share by Application (2026-2031)
Table 65. Global Daptomycin API Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Daptomycin API Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Daptomycin API Revenue Market Share by Application (2020-2025)
Table 68. Global Daptomycin API Revenue Market Share by Application (2026-2031)
Table 69. Global Daptomycin API Price (US$/Ton) by Application (2020-2025)
Table 70. Global Daptomycin API Price (US$/Ton) by Application (2026-2031)
Table 71. Xellia Pharmaceuticals Company Information
Table 72. Xellia Pharmaceuticals Description and Business Overview
Table 73. Xellia Pharmaceuticals Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 74. Xellia Pharmaceuticals Daptomycin API Product
Table 75. Xellia Pharmaceuticals Recent Developments/Updates
Table 76. Rochem International Inc Company Information
Table 77. Rochem International Inc Description and Business Overview
Table 78. Rochem International Inc Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 79. Rochem International Inc Daptomycin API Product
Table 80. Rochem International Inc Recent Developments/Updates
Table 81. Tecoland Corporation Company Information
Table 82. Tecoland Corporation Description and Business Overview
Table 83. Tecoland Corporation Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Tecoland Corporation Daptomycin API Product
Table 85. Tecoland Corporation Recent Developments/Updates
Table 86. Livzon Group Fuzhou Fuxing Pharmaceutical Co Company Information
Table 87. Livzon Group Fuzhou Fuxing Pharmaceutical Co Description and Business Overview
Table 88. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 89. Livzon Group Fuzhou Fuxing Pharmaceutical Co Daptomycin API Product
Table 90. Livzon Group Fuzhou Fuxing Pharmaceutical Co Recent Developments/Updates
Table 91. Chongqing DaXin Pharmaceutical Co Company Information
Table 92. Chongqing DaXin Pharmaceutical Co Description and Business Overview
Table 93. Chongqing DaXin Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 94. Chongqing DaXin Pharmaceutical Co Daptomycin API Product
Table 95. Chongqing DaXin Pharmaceutical Co Recent Developments/Updates
Table 96. Suzhou Pharmaceutical Technology Co Company Information
Table 97. Suzhou Pharmaceutical Technology Co Description and Business Overview
Table 98. Suzhou Pharmaceutical Technology Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 99. Suzhou Pharmaceutical Technology Co Daptomycin API Product
Table 100. Suzhou Pharmaceutical Technology Co Recent Developments/Updates
Table 101. Huazhong Pharmaceutical Co Company Information
Table 102. Huazhong Pharmaceutical Co Description and Business Overview
Table 103. Huazhong Pharmaceutical Co Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 104. Huazhong Pharmaceutical Co Daptomycin API Product
Table 105. Huazhong Pharmaceutical Co Recent Developments/Updates
Table 106. Athos Company Information
Table 107. Athos Description and Business Overview
Table 108. Athos Daptomycin API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 109. Athos Daptomycin API Product
Table 110. Athos Recent Developments/Updates
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. Daptomycin API Distributors List
Table 114. Daptomycin API Customers List
Table 115. Daptomycin API Market Trends
Table 116. Daptomycin API Market Drivers
Table 117. Daptomycin API Market Challenges
Table 118. Daptomycin API Market Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Product Picture of Daptomycin API
Figure 2. Global Daptomycin API Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Daptomycin API Market Share by Type: 2024 & 2031
Figure 4. 99% Product Picture
Figure 5. 98% Product Picture
Figure 6. Others Product Picture
Figure 7. Global Daptomycin API Market Value by Marketing Channel, (US$ Million) & (2020-2031)
Figure 8. Global Daptomycin API Market Share by Marketing Channel: 2024 VS 2031
Figure 9. Direct Sales Product Picture
Figure 10. Channel Sales Product Picture
Figure 11. Global Daptomycin API Market Value by Application (2020-2031) & (US$ Million)
Figure 12. Global Daptomycin API Market Share by Application: 2024 & 2031
Figure 13. 350mg/vial
Figure 14. 500mg/vial
Figure 15. Others
Figure 16. Global Daptomycin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Daptomycin API Market Size (2020-2031) & (US$ Million)
Figure 18. Global Daptomycin API Sales (2020-2031) & (Tons)
Figure 19. Global Daptomycin API Average Price (US$/Ton) & (2020-2031)
Figure 20. Daptomycin API Report Years Considered
Figure 21. Daptomycin API Sales Share by Manufacturers in 2024
Figure 22. Global Daptomycin API Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Daptomycin API Players: Market Share by Revenue in Daptomycin API in 2024
Figure 24. Daptomycin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Daptomycin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Daptomycin API Sales Market Share by Country (2020-2031)
Figure 27. North America Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 28. United States Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Daptomycin API Sales Market Share by Country (2020-2031)
Figure 31. Europe Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 32. Germany Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Daptomycin API Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Daptomycin API Revenue Market Share by Region (2020-2031)
Figure 39. China Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Daptomycin API Sales Market Share by Country (2020-2031)
Figure 49. Latin America Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Daptomycin API Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Daptomycin API Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Daptomycin API Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Daptomycin API by Type (2020-2031)
Figure 59. Global Revenue Market Share of Daptomycin API by Type (2020-2031)
Figure 60. Global Daptomycin API Price (US$/Ton) by Type (2020-2031)
Figure 61. Global Sales Market Share of Daptomycin API by Application (2020-2031)
Figure 62. Global Revenue Market Share of Daptomycin API by Application (2020-2031)
Figure 63. Global Daptomycin API Price (US$/Ton) by Application (2020-2031)
Figure 64. Daptomycin API Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global UV Delayed Curing Adhesives Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Die-Casting Die Steel Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Global Adaptive Neuromodulation Therapy Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 04, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232